Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SchrodingerSTU:43Z -1.35%56 OCF Margin % is -25.32% as of Mar. 2026. GuruFocus rates STU:43Z with a GF Score™ of 56/100 and a GF Value™ of €22.92 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 667 Healthcare Providers & Services companies, Schrodinger ranks worse than 89.81% on this metric.
The historical rank and industry rank for Schrodinger's OCF Margin % or its related term are showing as below:
STU:43Z'
s OCF Margin % Range Over the Past 10 Years
Min: -75.83 Med: -35.58 Max: 15.5
Current: -56.89
During the past 9 years, the highest OCF Margin % of Schrodinger was 15.50%. The lowest was -75.83%. And the median was -35.58%.
STU:43Z's OCF Margin % is ranked worse than 89.81% of 667
companies
in the Healthcare Providers & Services industry
Industry Median: 8.29
vs STU:43Z: -56.89
Schrodinger OCF Margin % Related Terms
Schrodinger OCF Margin % Historical Data
* Premium members only.
The historical data trend for Schrodinger's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:43Z vs OMDA, TDOC, GDRX: OCF Margin % Comparison
For the Health Information Services subindustry, Schrodinger's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Schrodinger OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Schrodinger's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Schrodinger's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Schrodinger (STU:43Z) has a OCF Margin % of -25.32% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Schrodinger and its competitors. According to the industry distribution chart, Schrodinger ranks #599 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 89.8%.
Is Schrodinger's OCF Margin % too high?
Schrodinger's current OCF Margin % is -25.32%. Based on the distribution chart, Schrodinger ranks #599 out of 667 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Schrodinger has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Schrodinger's OCF Margin % compare to OMDA and TDOC?
According to the Healthcare Providers & Services industry distribution chart, Schrodinger ranks #599 out of 667 companies for OCF Margin %. This places Schrodinger in the lower half of its industry. The industry median OCF Margin % is 8.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.29, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Schrodinger and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Schrodinger's current OCF Margin % is -25.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schrodinger stock overvalued right now?
Based on GuruFocus' analysis, Schrodinger (STU:43Z) is currently considered Possible Value Trap. The stock's GF Value™ is €22.92, compared to a current price of €13.17 — trading 42.5% below its estimated fair value. The current OCF Margin % is -25.32%. Schrodinger's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Schrodinger (STU:43Z), the current OCF Margin % is -25.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Schrodinger (STU:43Z) Overvalued in 2026?
Based on GuruFocus' analysis, Schrodinger stock appears to be undervalued.
The current stock price of €13.17 is trading 42.5% below its estimated GF Value™ of €22.92.
GuruFocus considers Schrodinger to be Possible Value Trap.
Key valuation signals for STU:43Z:
OCF Margin %: -25.32%
GF Value™: €22.92 vs. price of €13.17 (42.5% below fair value)
No single metric tells the full story. See the STU:43Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
56GF Score
Get the complete analysis for STU:43Z
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:43Z has been successfully added to your 
